Armis Centrix™ for VIPR vs Conviso Vuln Intelligence: Side-by-Side Comparison (2026)

Armis Centrix™ for VIPR: Healthcare-focused vuln mgmt platform for medical device security & risk prioritization. built by Armis. Core capabilities include Real-time medical device inventory and visibility, Vulnerability detection and deduplication, Clinical Impact Score for patient safety prioritization..

Conviso Vuln Intelligence: Risk-based vuln mgmt platform centralizing findings from multiple scanners. built by Conviso. Core capabilities include Risk-based vulnerability prioritization, Multi-scanner integration and findings correlation, Vulnerability deduplication..

Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.

Armis Centrix™ for VIPR differentiates with Real-time medical device inventory and visibility, Vulnerability detection and deduplication, Clinical Impact Score for patient safety prioritization. Conviso Vuln Intelligence differentiates with Risk-based vulnerability prioritization, Multi-scanner integration and findings correlation, Vulnerability deduplication.

Armis Centrix™ for VIPR is developed by Armis. Conviso Vuln Intelligence is developed by Conviso. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

Armis Centrix™ for VIPR and Conviso Vuln Intelligence serve similar Vulnerability Assessment use cases: both are Vulnerability Assessment tools, both cover Vulnerability Prioritization. Review the feature comparison above to determine which fits your requirements.